KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Cash & Current Investments (2016 - 2026)

Aurinia Pharmaceuticals filings provide 9 years of Cash & Current Investments readings, the most recent being $398.0 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 11.02% to $398.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $398.0 million, a 11.02% increase, with the full-year FY2025 number at $398.0 million, up 11.02% from a year prior.
  • Cash & Current Investments hit $398.0 million in Q4 2025 for Aurinia Pharmaceuticals, up from $351.8 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $466.1 million in Q4 2021 to a low of $286.4 million in Q3 2021.
  • Median Cash & Current Investments over the past 5 years was $350.6 million (2023), compared with a mean of $356.6 million.
  • Biggest five-year swings in Cash & Current Investments: soared 37.15% in 2021 and later dropped 16.45% in 2022.
  • Aurinia Pharmaceuticals' Cash & Current Investments stood at $466.1 million in 2021, then dropped by 16.45% to $389.4 million in 2022, then dropped by 9.99% to $350.5 million in 2023, then increased by 2.28% to $358.5 million in 2024, then increased by 11.02% to $398.0 million in 2025.
  • The last three reported values for Cash & Current Investments were $398.0 million (Q4 2025), $351.8 million (Q3 2025), and $315.1 million (Q2 2025) per Business Quant data.